MELISSA DESUEZA: Open Payments
NPI 1235634189 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,342 in 94 payments from 18 companies in 2025. Trend: 2023 $1,448 · 2024 $2,286 · 2025 $2,342
Food & beverage: $2,342
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $484 |
| ABBVIE INC. | 22 | $400 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $386 |
| Amgen Inc. | 9 | $263 |
| Lilly USA, LLC | 9 | $158 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Exact Sciences Corporation | 4 | $95 |
| Dexcom, Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Corcept Therapeutics | 4 | $77 |
Products named: JARDIANCE, Ozempic, LINZESS, OTEZLA, REZDIFFRA, MOUNJARO, Wegovy, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
